|
Volumn 333, Issue 6047, 2011, Pages 1254-1256
|
Synthetic biology: Regulating industry uses of new biotechnologies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOFUEL;
CEFALEXIN;
DNA;
ISOPRENE;
OLIGONUCLEOTIDE;
POLYHYDROXYALKANOIC ACID;
SITAGLIPTIN;
BACTERIUM;
BIOFUEL;
BIOTECHNOLOGY;
CHROMOSOME;
COMMERCIALIZATION;
DRUG;
BACTERIAL CHROMOSOME;
BIOENGINEERING;
BIOSAFETY;
BIOTECHNOLOGY;
CELL NUCLEUS TRANSPLANTATION;
COMPUTER AIDED DESIGN;
COST CONTROL;
DNA SEQUENCE;
DNA SYNTHESIS;
DRUG MANUFACTURE;
GENE EXPRESSION;
GENETIC ANALYSIS;
GENETIC CODE;
GENETIC SCREENING;
GENETIC TRAIT;
HUMAN;
LAW;
NONHUMAN;
OIL SPILL;
PRIORITY JOURNAL;
REVIEW;
SAFETY;
SOMATIC CELL;
STANDARDIZATION;
SYNTHETIC BIOLOGY;
BIOETHICAL ISSUES;
BIOTECHNOLOGY;
DIFFUSION OF INNOVATION;
GENETIC ENGINEERING;
GOVERNMENT REGULATION;
GUIDELINES AS TOPIC;
PUBLIC POLICY;
SYNTHETIC BIOLOGY;
UNITED STATES;
BACTERIA (MICROORGANISMS);
|
EID: 80052501954
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1211066 Document Type: Review |
Times cited : (33)
|
References (23)
|